QCast: Data-Driven Dialogue in Drug Development podcast

Episode 73: Respiratory Clinical Trials

0:00
9:34
Spol 15 sekunder tilbage
Spol 15 sekunder frem

Respiratory clinical trials cover a wide spread of conditions, from asthma and COPD to idiopathic pulmonary fibrosis, chronic cough and Long COVID, and each one asks something different of a study design. In this QCast episode, co-hosts Jullia and Tom look at why endpoints such as FEV1, FVC, exacerbation rates and patient-reported outcomes can’t be swapped for one another.

Key Takeaways

  • Design should start from the indication. An IPF study asks whether decline slows over time, while an asthma study may target exacerbations or steroid reduction in a biomarker-defined group.
  • Exacerbation endpoints only work if every site defines and captures events the same way. The estimand should settle early how rescue medication and background therapy changes are handled in the analysis.
  • Spirometry depends on patient effort and operator technique, so ATS/ERS standardisation and early central review protect the primary endpoint. Home devices and e-diaries still need active review of incoming data.


🔗 Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial.
📝 Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast.
🔔 Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode.

About Quanticate

Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in:

  • Clinical Data Capture & Management
  • Biostatistics & Statistical Consultancy
  • Statistical Programming & PK/PD Analysis
  • Medical Writing & Pharmacovigilance
  • Regulatory & Submission Support
  • AI & Automation
  • Post-Marketing Safety & Real-World Data

Quanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.

Flere episoder fra "QCast: Data-Driven Dialogue in Drug Development"